All resources

April 24, 2026

The value of the innovative pharmaceutical industry – A report summary

This summary of a study by Deloitte combines a traditional economic impact analysis with targeted assessments of health system impacts […]

Learn more | View

February 24, 2026

Increasing access to innovative medicines

Written Submission for the Pre-Budget Consultations in Advance of the 2026-2027 New Brunswick Budget

Learn more | View

February 18, 2026

Increasing access to innovative medicines

Written Submission for the Pre-Budget Consultations in Advance of the 2026 Newfoundland and Labrador Budget

Learn more | View

February 06, 2026

Pre-budget submission 2026

Innovative Medicines Canada (IMC) is pleased to contribute to the Quebec government’s consultations on its 2026-27 budget. Availability of and […]

Learn more | View

January 30, 2026

Increasing access to innovative medicines

Written Submission for the Pre-Budget Consultations in Advance of the 2026 Ontario Budget January 2026

Learn more | View

January 15, 2026

Increasing access to innovative medicines

Written Submission for the Pre-Budget Consultations in Advance of the 2026 Alberta Budget

Learn more | View

December 15, 2025

Increasing access to innovative medicines

Written Submission for the Pre-Budget Consultations in Advance of the 2026 Nova Scotia Budget

Learn more | View

November 03, 2025

Submission to the Government of Canada’s consultation on the review of the Canada – United States -Mexico agreement

Learn more | View

October 28, 2025

The private drug insurance market in Canada saw a 7.3% total cost growth in 2023-2024, primarily driven by increased utilization which accounted for 60% of total cost growth. The number of claimants rose by 3.5%, with claimants making
0.9% more claims.

Learn more | View

September 26, 2025